aTYR PHARMA CEO Sanjay Shukla's 2020 pay jumps 63% to $1.1M
aTYR PHARMA reports 2020 executive compensation
By ExecPay News
Published: March 23, 2021
aTYR PHARMA reported fiscal year 2020 executive compensation information on March 23, 2021.
In 2020, three executives at aTYR PHARMA received on average a compensation package of $803K, a 54% increase compared to previous year.
Average pay of disclosed executives at aTYR PHARMA
Sanjay S. Shukla, Chief Executive Officer, received $1.1M in total, which increased by 63% compared to 2019. 43% of Shukla's compensation, or $470K, was in salary. Shukla also received $223K in non-equity incentive plan, $382K in option awards, as well as $8.4K in other compensation.
Jill M. Broadfoot, Chief Financial Officer, received a compensation package of $699K, which increased by 54% compared to previous year. 52% of the compensation package, or $366K, was in salary.
Nancy E. Denyes, General Counsel, earned $625K in 2020, a 39% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on March 23, 2021.